FGL1 and metabolic dysfunction-associated steatotic liver disease: Excessive FGL1 causes hepatic lipid accumulation, inflammation, and insulin resistance, leading to nonalcoholic fatty liver disease (NAFLD), obesity, and type 2 diabetes (12–14).